Hindawi Publishing Corporation
Mediators Inï¬‚ammation
Volume 2014, Article ID 893634, 17 pages
http://dx.doi.org/10.1155/2014/893634




Research Article Acute Phase Trypanosoma cruzi Infection Attenuated 5-Lipoxygenase-Deficient Mice

          Adriana M. C. Canavaci,1 Carlos  Sorgi,1 Vicente P. Martins,2 Fabiana R. Morais,1
          Ã‰rika V. G. Sousa,1 Bruno C. Trindade,1 Fernando Q. Cunha,3 Marcos  Rossi,4
          David M. Aronoff,5 LÃºcia H. Faccioli,1 Auro Nomizo1
          1
            Departamento alises ClÂ´Ä±nicas, ToxicolÂ´ogicas e BromatolÂ´ogicas, Faculdade CiË†encias FarmacË†euticas RibeirËœao Preto,
            Universidade SËœao Paulo, Avenida CafÂ´e, s/n, 14040-903 RibeirËœao Preto, SP, Brazil
          2
            Departamento Biologia Celular, Instituto CiË†encias BiolÂ´ogicas, Universidade BrasÂ´Ä±lia, Campus Darcy Ribeiro,
            70910-900 BrasÂ´Ä±lia, DF, Brazil
          3
            Departamento Farmacologia, Faculdade Medicina RibeirËœao Preto, Universidade SËœao Paulo, Avenida Bandeirantes,
             3900, 14049-900 RibeirËœao Preto, SP, Brazil
          4
            Departamento Patologia, Faculdade Medicina RibeirËœao Preto, Universidade SËœao Paulo, Avenida Bandeirantes,
             3900, 14049-900 RibeirËœao Preto, SP, Brazil
          5
            Division Infectious Diseases, Department Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA

          Correspondence addressed Auro Nomizo; aunomizo@fcfrp.usp.br

          Received 4 April 2014; Revised 12 June 2014; Accepted 17 June 2014; Published 3 August 2014

          Academic Editor: Marcelo T. Bozza

          Copyright Â© 2014 Adriana M. C. Canavaci et al. open access article distributed Creative Commons Attribution
          License, permits unrestricted use, distribution, reproduction medium, provided original work properly cited.

          present work examine contribution 5-lipoxygenase- (5-LO-) derived lipid mediators immune responses           acute phase Trypanosoma cruzi infection 5-LO gene knockout (5-LOâˆ’/âˆ’ ) mice wild-type (WT) mice. Compared           WT mice, 5-LOâˆ’/âˆ’ mice developed parasitemia/tissue parasitism, inflammatory cell infiltrates, lower mortality.
          resistance 5-LOâˆ’/âˆ’ mice correlated differences immune response infection, including reduced PGE2
          synthesis; sustained capacity splenocytes produce high levels interleukin  -12 early infection; enhanced splenocyte
          production 1ð?›½, 6, IFN-ð?›¾; rapid T-cell polarization secrete high quantities IFN-ð?›¾ low quantities 10;           greater numbers CD8+ CD44high CD62Llow memory effector T cells end acute phase infection. high mortality
          WT mice associated increased production LTB4 /LTC4 , T cell bias produce IFN-ð?›¾, high levels serum nitrite,
          marked protein extravasation peritoneal cavity, survival improved treatment cys-LT receptor 1
          antagonist. data provide evidence 5-LO-derived mediators negatively affect host survival acute phase           T. cruzi infection.




1. Introduction                                                            cytoplasm [2]. acute phase disease                                                                            characterized marked increase parasite replication
Infection Trypanosoma cruzi (T. cruzi), obligate intra-            migration blood, potentially leading systemic
cellular protozoan parasite, causes American trypanosomia-                 infection.  immunocompetent hosts able sis Chagas disease, zoonosis endemic Latin America.                generate innate inflammatory specific immune responses
Approximately 60 million people live areas vector-                 acute secondary infection, controlling parasite
borne transmission risk disease causes estimated                burden [3]. responses primarily dependent 14,000 deaths year [1]. entering host, T. cruzi              cytokine/chemokine mediated activation infected phago-
invades variety cell types, macrophages, heart                cytes tissue cells leads intracellular killing
muscle cells, skeletal muscle cells, neurons, replicating              [4], complete elimination parasite rarely
2                                                                                                    Mediators Inflammation

achieved. Parasite persistence tissues followed       5-LO pathway activity modulate asymptomatic indeterminate phase, chronic chagasic         T. cruzi infection. address issue, studied
immunopathology develops approximately 25  cases            specifically acute phase T. cruzi infection 5-LOâˆ’/âˆ’
[5].                                                              mice.
     factors governing immunological resistance acute
trypanosomiasis fully understood. Host genetic       2. Materials Methods
ground parasite strain differences relevant [6].
Early, partial control parasites infected tissue     2.1. Animals. Male mice (18â€“20 g) used; 5-LOâˆ’/âˆ’
achieved local production type 1 IFNs [7], 1ð?›½ [8],       (129-Alox5tm1Fun /J) strain-matched WT mice (129-SF2/J) ð?›½-chemokines [9].  effective parasite control       purchased Jackson Laboratories (Bar Harbor, .
likely requires participation innate adaptive     animal colony bred maintained specific
immune cells including macrophages, dendritic cells, NK       pathogen-free conditions Faculdade CiË†encias Far-
cells secrete proinflammatory cytokines (e.g., 12      macË†euticas RibeirËœao Preto (Universidade SËœao Paulo,
IFN-ð?›¾) [10] naive T cells generation parasite-     Brazil). study approved carried strict
specific CD4+ CD8+ effector T cells [11], produce       accordance guidelines Animal Care Commit-
Th1 cytokines IFN-ð?›¾  lesser quantities, Th2        tee Universidade SËœao Paulo Biosafety Com-
cytokines 4 10 [12, 13].                        mittees (Process nos. 05.1.592.53.2 CQB-0019/97).      immune functions assigned                 euthanasia performed CO2 /O2 excess atmosphere, number polypeptide mediators (cytokines               efforts minimize suffering.
chemokines) host defense T. cruzi, little attention paid role lipid mediators. lipid
                                                                  2.2. Parasite Infection Pharmacological Treatment. Mice
molecules mainly eicosanoids generated                                                                   infected intraperitoneally 200 units blood effects cyclooxygenases (COX) 5-lipoxygenase
                                                                  form T. cruzi (Colombian strain) 0.2 mL 0.15 M PBS.
(5-LO) play variety roles regulating host innate
                                                                  Control mice received volume sterile PBS. Par- adaptive immune responses [14]. 5-LO pathway
                                                                  asites counted 5 ð?œ‡L blood previously described
leads formation biologically relevant classes
                                                                  [32]. WT mice previously subjected T. cruzi infection leukotrienes (LTs): non-cysteinyl LTs LTB4 ;                                                                   [33]. experiments, infected WT mice treated
cysteinyl-LTs (cys-LTs) LTC4 , LTD4 , LTE4 [15];
                                                                  cys-LT receptor 1 antagonist, montelukast (10 mg/kg, activity 5-LO common step LXA4
                                                                  Singulair; Merck Sharp & Dohme, Campinas, Brazil) synthesis [16]. LTs established play protective
                                                                  vehicle, carboxymethylcellulose (0.5  w/v), administered
roles infection microbial pathogens,
                                                                  orally gavage (300 ð?œ‡L/animal) postinoculation days
including Salmonella typhimurium, Pseudomonas aeruginosa
                                                                  14â€“32, starting day 14 given 2 days. T. cruzi
[17], Klebsiella pneumoniae [18], vesicular stomatitis
                                                                  soluble antigens obtained trypomastigote forms
virus encephalitis [19], Histoplasma capsulatum [20].
                                                                  (Colombian strain) used vitro experiments [32].  settings 5-LO products shown
                                                                  Briefly, trypomastigotes washed twice cold PBS, play contradictory roles, example, Mycobacterium
                                                                  subjected freeze-thaw cycles, centrifuged (9000 Ã—g,
tuberculosis infection models [21, 22]. addition, cecal
                                                                  10 min, 4âˆ˜ C). supernatant filtered 0.22 ð?œ‡m
ligation puncture model peritonitis, LTs exhibited
                                                                  pore size membrane filter, protein concentration beneficial effects local immunity exhibited deleterious
                                                                  measured using colorimetric assay (Pierce, Rockford, .
effects hemodynamic responses [23]. Immunoregulatory
lipids, arachidonic acid-derived eicosanoids, increasingly implicated pathogenesis parasitic      2.3. Histology Quantitative Tissue Parasite Nest Determi-
infections [24, 25]. 5-LO pathway products               nation. Histology tissue parasite counts performed implicated modulating pathogenesis               described [11]. Briefly, tissue samples fixed parasitic infections results         4  buffered formalin processed conventional contradictory. vitro, LTB4 LTC4 potentiate            paraffin embedding day 16 infection. Sections (8 ð?œ‡m)
macrophages kill T. cruzi [26, 27] Leishmania              deparaffinized stained hematoxylin eosin.
amazonensis [28].  mediators              Intact parasite nests evaluated blinded samples implicated conferring susceptibility Schistosoma            counting number parasites nests 100 microscopic
mansoni [29], Strongyloides venezuelensis [30], cerebral      fields/sample nonconsecutive sections.
malaria [31], suggesting LTs play conflicting
roles parasite infection.                                  2.4. Eicosanoid Levels Peritoneal Cell Supernatants. Peri-
     immunoregulatory effects 5-LO pathway                 toneal cells collected intraperitoneal injection 4 mL
eicosanoids complex context dependent.              cold PBS uninfected controls, infected WT, 5- net effects beneficial host defense     LOâˆ’/âˆ’ mice various time points infection. Cell concen-
microbial pathogens, necessarily true         tration adjusted 106 cells mLâˆ’1 Hankâ€™s buffered salt
infections. light importance regulating immune       solution (HBSS; Sigma, St. Louis, MO) Ca+2 Mg+2 .
responses parasitic infections, contrasting roles      Cells stimulated 0.5 ð?œ‡M calcium ionophore
exhibited LTs infection models, asked            A23187 (Sigma, Saint Louis, EUA) 15 min 37âˆ˜ C Mediators Inflammation                                                                                                       3

humidified atmosphere 5  CO2 . supernatants            2.9. Protein Extravasation. Protein extravasation 
harvested PGE2 , LTB4 , LTC4 levels determined        sessed previously described [23]. Control mice infected specific EIA kit, following manufacturerâ€™s instructions     mice v. injected Evans blue dye (50 mg/kg (GE Healthcare, Little Chalfont, UK).                              volume 0.1 mL; Sigma, Saint Louis, EUA). 1 h,
                                                                   mice euthanized CO2 inhalation, peritoneal
                                                                   exudates recovered injecting 2 mL PBS. peri-
2.5. Spleen Cell Culture. Mice experimental groups
                                                                   toneal exudates centrifuged 10 min 200 Ã—g, euthanized various days inoculation. Single-cell
                                                                   supernatant saved colorimetric determinations. suspensions prepared passing spleen                                                                    OD determined 630 nm automated microplate 70 ð?œ‡m cell strainer (Falcon, Sollentuna, Sweden).                                                                    reader.
splenocytes washed 3 times HBSS, counted hemocytometer, assessed viability, suspended RPMI 1640 medium supplemented 10  FCS, peni-
                                                                   2.10. Vitro Macrophage Infection. Peritoneal cells WT
cillin (100 U/mL), streptomycin (100 ð?œ‡g/mL), gentamicin
(50 ð?œ‡g/mL) (Gibco-Invitrogen, Carlsbad, CA) HBSS sup-           5-LOâˆ’/âˆ’ mice collected, washed twice, counted
plemented 5  FCS. cell concentration adjusted         cell concentration adjusted 106 cells/mL 107 cells/mL cultured 24 plates (Nalge Nunc,        supplemented RPMI medium. Cells attached 13 mm-
Rochester, NY) 1 mL supplemented RPMI medium,           diameter glass coverslips placed 24 plates (Nalge
5 ð?œ‡g anti-CD3ð?œ€ 10â€“50 ð?œ‡g soluble T. cruzi antigens    Nunc, Rochester, NY), 90 min 37âˆ˜ C atmosphere 37âˆ˜ C atmosphere 5  CO2 24â€“48 h. Supernatants      5  CO2 . nonadherent cells removed washings collected stored âˆ’70âˆ˜ C use.               warm supplemented RPMI medium. Peritoneal macrophages
                                                                   (PM) isolated procedure >90  pure measured
                                                                   staining F4/80+ (data shown). PMs 2.6. Metabolic Assays. Splenocytes (4 Ã— 105 cell         stimulated 6 h 5 ng/mL IFN-ð?›¾ (BD Pharmingen,
different experimental groups cultured quintuplicate       San Diego, CA) plus 0.1 ð?œ‡g/mL LPS Escherichia coli flat 96 microplates (Nalge Nunc, Rochester, NY)       (Sigma, Saint Louis, EUA) infected parasite 
supplemented RPMI medium. Cells cultured             macrophage ratio 5 : 1  2 h, glass coverslips anti-CD3ð?œ€ IgG (1 ð?œ‡g/mL; BD Pharmingen, San Diego,             washed times PBS remove free parasites, fixed
CA) 37âˆ˜ C humidified atmosphere 5  CO2 .          absolute methanol, stained Panoptic stain (Labor-
60 h, 10 ð?œ‡L (5 mg/mL) MTT (Sigma, Saint Louis, EUA)         clin, Pinhais, Brazil), dried, mounted glass slides, added  cells incubated additional     examined microscopically association (parasite adhered
4 h, followed addition 50 ð?œ‡L 20  SDS PBS           macrophages plus internalized parasites) previously stored dark overnight. Absorbance measured          described [26]. killing assay, noninternalized parasites 570 nm using automated microplate reader (ð?œ‡QUANT;            infected macrophages wells removed 24 h later BioTek Instruments, Winooski, VT).                                 gentle washes warm supplemented RPMI medium.
                                                                   Fresh supplemented RPMI medium added 2.7. Flow Cytometry. Spleen cells isolated described        infected macrophages cultured 37âˆ˜ C, placed ice-cold PBS supplemented 5  FCS          atmosphere 5  CO2 10 days, 50  0.1  sodium azide. Staining performed previ-            medium removed replaced volume
ously described [11]. following fluorochrome-conjugated        supplemented RPMI medium 48 h. 7â€“11 days
monoclonal antibodies used: anti-CD4 [H129.19]; anti-         infection, culture supernatants collected daily CD8 [53-6.7]; anti-CD19 [MB19-1]; anti-CD25 [7D4]; anti-           count number motile trypomastigotes 
CD44 [IM7]; anti-CD69 [H1.2F3]; anti-Gr-1/Ly6C/Ly6G
[RB6-8C5]; anti-CD45RB [16A]; anti-CD62L [MEL-14]; anti-
CD11b [M1/70] (BD Pharmingen, San Diego, CA); anti-            2.11. Nitrite/Nitrate Concentration. Tail-vein blood samples
CD11c [HL3]â€”(Serotech, Raleigh, NC) anti-F4/80 [CI:A3-             obtained day 22 inoculation. Nitrate serum
1] anti-GITR [DTA-1] (eBioscience, San Diego, CA).             samples converted nitrite nitrate reductase, staining, cells fixed 1  paraformaldehyde      serum levels nitrate/nitrite (Nitric oxide end-products PBS analyzed using FACSCanto (BD Biosciences,             metabolites) measured absorbance using Griess
San Jose, CA), 50,000 events/sample recorded. Data            Reaction (Calbiochem, La Jolla, CA) [34]. OD processed using FlowJo software (FlowJo LLC, Ashland, .         determined 540 nm ð?œ‡QUANT automated microplate
Cell numbers calculated using percentage obtained         reader. nitriteconcentration determined reference FACS analysis total numbers leukocytes counted       standard (1â€“100 ð?œ‡M) sodium nitrite curve. hemocytometer.
                                                                   2.12. Cytokine ELISA. Levels 1ð?›½, 2, 6, 10, 
2.8. T. cruzi-Specific Antibodies. Specific IgG, IgG1, IgG2a   12, TNF-ð?›¼, IFN-ð?›¾ quantified ELISA according determined mouse sera ELISA previously               manufacturerâ€™s instructions (BD Pharmingen, San Diego,
described [32]. individual titers considered          CA) splenocytes culture supernatant. lower limits
highest serum dilutions presented OD492 > 0.1.                detection cytokines 9.4 pg/mL.
4                                                                                                     Mediators Inflammation

2.13. Statistical Analysis. results presented means     infiltrates WT mice (Figure 2(c)) 5-LOâˆ’/âˆ’ mice
Â± SD, exception parasitemia, shown        (Figure 2(d)).
means Â± SEM. tests used evaluate differences groups mentioned figure legends. Values        3.4. Cytokine Production Spleen Cells. culture, ð?‘ƒ < 0.05 considered significant.                              spleen cells infected mice spontaneously produced 1ð?›½,
                                                                   6, TNF-ð?›¼, 10, 12, IFN-ð?›¾ (Figure 3). notable
                                                                   production cytokines greater
3. Results                                                         weeks infection, peaking day 12 3.1. Lipid Mediator Production Infected Peritoneal Cells.       inoculation, correlating parasitemia (Figure 1(c)). Peritoneal cells T. cruzi-infected mice (WT) released         general, production 6, 12, IFN-ð?›¾ greater
significantly LTB4 PGE2 calcium ionophore            spleen cells infected 5-LOâˆ’/âˆ’ WT cells. day
stimulation did cells obtained uninfected mice           5, production 1ð?›½, 6, 12, IFN-ð?›¾ higher
(Figures 1  1(b)). potential cells produce LTB4    5-LOâˆ’/âˆ’ cells WT cells TNF-ð?›¼ production elevated early time point inoculation (day 5)      lower. day 12, 1ð?›½ levels comparably high increased gradually infection, peaking       cell cultures mouse strains, spleen cells day 19. potential decreased drastically       infected 5-LOâˆ’/âˆ’ showed significantly greater production late phase acute infection (day 26; Figure 1 ).               6, 12, IFN-ð?›¾, TNF-ð?›¼ compared infected WT
     potential peritoneal cells T. cruzi-infected      cells. production 10 showed opposite trend
mice produce PGE2 increased (Figure 1(b)).             (Figure 3(d)). late phase infection  days 19 Peritoneal cells infected WT mice released PGE2 early      26), 5-LOâˆ’/âˆ’ spleen cells, contrast observed
time points (day 5) increased markedly subsequent           WT spleen cells, showed sustained elevation days, peaking day 12. PGE2 levels decreased drastically         production 1ð?›½ (Figure 3 ) 10 (Figure 3(d)), day 19 increased late phase             higher levels 12 (Figure 3(e)), lower levels IFN-ð?›¾
acute infection day 26. Peritoneal cells infected 5-       (Figure 3(f)).
LOâˆ’/âˆ’ mice showed enhanced production PGE2
(Figure 1(b)) pattern different observed      3.5. Cell Populations Spleen Infected Mice. Infection
WT cells did suggest shunting arachidonic acid          mice T. cruzi led accumulation Gr1+ cyclooxygenase pathway. PGE2 production 5-          cells  e., neutrophils), Gr1+ /CD11c+ cells  e., plasmacytoid
LOâˆ’/âˆ’ cells elevated day 5 increased day         dendritic cells), CD11b+ cells  e., myeloid lineage cells),
12 (albeit levels WT) level maintained      F4/80+ cells  e., macrophages) spleens infection. Notably, peritoneal cells      compared uninfected control mice (Figures 4 â€“4(d)).
WT 5-LOâˆ’/âˆ’ T. cruzi-infected mice appeared produce          Greater numbers Gr1+ , Gr1+ /CD11c+ , CD11b+ , F4/80+ PGs LTs, evidenced fact LTB4 levels       cells present 5-LOâˆ’/âˆ’ WT spleens day
(Figure 1 ) far lower PGE2 (Figure 1(b)).     12 infection (Figures 4 â€“4(c)). Macrophage (F4/80+ )
                                                                   numbers higher spleens 5-LOâˆ’/âˆ’ mice day 19
                                                                   infection compared WT mice (Figure 4(d)).
                                                                   addition, day 5 infection, plasmacytoid dendritic
3.2. Control Parasite Dissemination Host Survival                                                                    cell (Gr1+ /CD11c+ ) counts higher infected 5-LOâˆ’/âˆ’
Infection. shown Figure 1(c), infected 5-LOâˆ’/âˆ’ mice          mice, compared infected WT mice (Figure 4(b)).
presented delay appearance blood-circulating           notable myeloid lineage cells numbers higher
parasites low parasite numbers second peak      spleens infected WT animals spleens 5-
parasitaemia compared WT mice. addition, number
                                                                   LOâˆ’/âˆ’ mice (Figure 4(c)). intact parasite nests heart muscle tissue considerably
lower 5-LOâˆ’/âˆ’ mice (Figure 1(d)). Furthermore,            3.6. Peritoneal Macrophage Infection. infected 5-LOâˆ’/âˆ’
17  5-LOâˆ’/âˆ’ mice died postinoculation days 16â€“           mice, PMs IFN-ð?›¾ increased (Figures 4(d) 19, WT mice did begin die day 19              3(f)). vitro infection peritoneal LPS-plus IFN-ð?›¾-
(Figure 1(e)). acute phase infection, 30         activated-macrophages WT 5-LOâˆ’/âˆ’ mice showed
WT mice capable surviving infection. contrast,      differences association macrophages parasites
82.3  5-LOâˆ’/âˆ’ mice controlled parasite efficiently          (binding internalization) ability kill
survived acute phase infection (Figure 1(e)).               intracellular parasites (Figures 4(e) 4(f)). Compared                                                                    activated PMs WT mice, 5-LOâˆ’/âˆ’ mice
3.3. Inflammatory Infiltrate Tissue Parasitism      presented greater capacity associate blood form
Acute Phase T. cruzi Infection. Analysis histological    parasite, evidenced higher numbers bound
samples heart muscle tissue collected 16 days       internalized parasites (Figure 4(e)). Activated PMs inoculation revealed WT mice presented intact            5-LOâˆ’/âˆ’ mice efficient killing internalized
parasite nests amastigote forms              parasites, evidenced lower numbers parasites
nests (Figure 2 ) did 5-LOâˆ’/âˆ’ mice (Figure 2(b)).        recovered vitro infection compared WT PMs
addition, greater inflammatory mononuclear cell         (Figure 4(f)).
Mediators Inflammation                                                                                                                                                                                                      5


                                     160                                                            âˆ—                                                              25000
                                                                                                                                                                                                 âˆ—

                                                                                                                                                                   20000
                                     120




                                                                                                                            PGE2 (pg/mL)
            LTB4 (pg/mL)



                                                                     âˆ—                                                                                             15000
                                            80                                                                                                                                                                         âˆ—
                                                                                                                                                                   10000                                                   #
                                                        âˆ—                                                                                                                                             #           #        âˆ—
                                                                                                                                                                                   âˆ—                  âˆ—           âˆ—
                                            40                                                                    âˆ—
                                                                                                                                                                    5000
                                                                           #                                                                                                           #                    âˆ—
                                                            #                                                         #                                                                âˆ—
                                                                                                        #
                                             0                                                                                                                           0
                                                       5          12             19                             26                                                             5            12             19         26
                                                                 Days infection                                                                                                      Days infection

                                                      WT                                            WT infected                                                               WT                           WT infected
                                                      5-LOâˆ’/âˆ’                                       5-LOâˆ’/âˆ’ infected                                                          5-LOâˆ’/âˆ’                      5-LOâˆ’/âˆ’ infected

                                                                                                                                                                                              (b)
                                                  6
                                            Ã—10
                                            2.0
                                                                                                                                                                   150
                                                                                                                                Number parasites nests/100 mf
                 Number parasites (mL)




                                            1.5

                                                                                                                                                                   100
                                            1.0


                                            0.5                                                                                                                     50
                                                                 #                             # # #
                                                                                                     #
                                             0                                                                                                                                                                    #
                                                  0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32
                                                                                                                                                                     0
                                                                 Days infection

                                                       WT                                                                                                                    WT
                                                       5-LOâˆ’/âˆ’                                                                                                               5-LOâˆ’/âˆ’
                                                                      (c)                                                                                                                       (d)
                                                                                              100
                                                                                               90                                                                                  P < 0.0001
                                                                                               80
                                                                                               70
                                                                               Survival ( )




                                                                                               60
                                                                                               50
                                                                                               40
                                                                                               30
                                                                                               20
                                                                                               10
                                                                                                0
                                                                                                    0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32
                                                                                                               Days infection
                                                                                                            WT
                                                                                                            5-LOâˆ’/âˆ’
                                                                                                                          (e)

Figure 1: Lipid mediator production, parasitemia, tissue parasitism, survival rate WT 5-LOâˆ’/âˆ’ mice infected T. cruzi: (  (b)) LTB4 PGE2 : peritoneal cells collected control, infected WT, infected 5-LOâˆ’/âˆ’ mice (ð?‘› = 10/group) stimulated calcium ionophore. âˆ— ð?‘ƒ < 0.01 versus uninfected group; # ð?‘ƒ < 0.01 versus WT infected mice. (c) Parasitemia (ð?‘› = 10 mice/group). # ð?‘ƒ < 0.001
versus infected WT mice. (d) Parasite nests heart tissue postinoculation day 16. âˆ— ð?‘ƒ < 0.001 versus infected WT mice. (e) Survival: WT
mice (squares) 5-LOâˆ’/âˆ’ mice (triangles), ð?‘› = 10 animals/group. Wilcoxon signed-rank test (level significance, ð?‘ƒ < 0.001). Data representative independent experiments.
6                                                                                                           Mediators Inflammation

                                             WT                                           5-LOâˆ’/âˆ’




                    Parasite nests




                                                                                           (b)
                   Inflammatory infiltrate




                                             (c)                                             (d)

Figure 2: Histopathological analysis heart tissue parasitism inflammatory infiltrate T. cruzi-infected WT 5-LOâˆ’/âˆ’ mice
(ð?‘› = 8/group) postinoculation day 16 (staining H&E; magnification, Ã—200):   section WT mouse, showing numerous large
amastigote nests, (b) section 5-LOâˆ’/âˆ’ mouse, showing fewer, smaller nests, (c) section WT mouse, showing intense mononuclear
cell infiltration, (d) section 5-LOâˆ’/âˆ’ mouse, showing infiltration. Photomicrographs experiment representative independent experiments.



3.7. Spleen B-Cell Counts Serum Levels Parasite-Specific        WT 5-LOâˆ’/âˆ’ infected mice. infected mice, majority
Immunoglobulins. shown Figure 5 , splenic CD19+ B-             splenic T-cell populations presented late T-cell
cell counts greater mice infected T. cruzi           activation markers CD4+ CD44+ CD8+ CD44+ (Figures control mice. day 5 inoculation, splenic CD19+             6(c) 6(d)). day 5 inoculation, numbers cell counts elevated infected WT mice gradually            T-cell phenotypes elevated infected WT mice,
returned baseline values end acute phase           gradually increasing course infection peaking
infection. contrast, splenic CD19+ cell counts increased            day 26, study endpoint (Figure 6). contrast, infected
significantly infected 5-LOâˆ’/âˆ’ mice       5-LOâˆ’/âˆ’ mice presented delayed elevation T-cell counts,
weeks infection, gradually significantly              increase activated T-cell phenotypes
elevated WT mice later phase infection.                 pronounced observed WT spleens. Infected
     Mice infected T. cruzi produced detectable levels         5-LOâˆ’/âˆ’ mice presented significant increase CD4+ CD44+
parasite-specific IgG antibodies time-dependent manner            CD8+ CD44+ counts day 12, marked increase later phase infection (Figure 5(b)). principal       CD4+ CD69+ count day 19, slight significant
isotype produced infection IgG2a, levels             increase CD8+ CD69+ CD4+ CD25+ counts day
IgG1 low. Compared WT mice, 5-LOâˆ’/âˆ’ mice                     26.
presented lower levels parasite-specific IgG day 26, parasite-specific IgG2a days 19 26             3.9. T-Cells Properties, Cytokine Production, CD4+ Mem-
infection.
                                                                       ory T Cells Expressing CD45RBð?‘™ð?‘œð?‘¤ CD44â„Žð?‘–ð?‘”â„Ž CD62Lð?‘™ð?‘œð?‘¤                                                                        Spleen. shown Figure 7 , spleen cells 3.8. T-Cell Phenotypes Spleens Infected Mice. indi-       control mice proliferated stimulation anti-CD3ð?œ€,
cated Figure 6, infected mice presented elevated CD4+           expected, spleen cells collected infected
CD8+ T-cell counts, markers CD4+ CD69+ , CD8+ CD69+ ,              WT mice day 12 inoculation stimulated CD4+ CD25+ , CD4+ CD44+ , CD8+ CD44+ , indi-                 anti-CD3ð?œ€ presented dramatic reduction proliferation.
cate presence activated T-cells spleens           spleen cells infected 5-LOâˆ’/âˆ’ mice day 12
Mediators Inflammation                                                                                                                                                         7




                               150                         1ð?›½                                            250                                 6

                                                           âˆ—                                                                                    #
                               125                                                                                                              âˆ—
                                                     âˆ—                                                      200
                               100
               1ð?›½ (pg/mL)




                                                                                             6 (pg/mL)
                                                                                                            150                          âˆ—
                                75
                                                                         #                                  100               #
                                50                                                    #                                       âˆ—
                                              #                          âˆ—            âˆ—
                                              âˆ—
                                25                                                                           50

                                 0                                                                            0
                                      5            12               19           26                                   5                12               19           26
                                                  Days infection                                                                Days infection
                                                                                                                                       (b)
                                                                                                                                          10
                               120                         TNF-ð?›¼                                            250                          #
                                          âˆ—                                                                                              âˆ—

                                                                                                            200
                                90
               TNF-ð?›¼ (pg/mL)




                                                                                           10 (pg/mL)


                                                                                                            150
                                                                                                                          âˆ— âˆ—                   #
                                60                                                                                                              âˆ—
                                              #           #
                                              âˆ—           âˆ—                                                 100                                                               #
                                                                                                                                                                 #            âˆ—
                                                                                                                                                                 âˆ—
                                30
                                                                                                            50


                                 0                                                                            0
                                      5            12             19            26                                    5                12               19           26
                                                  Days infection                                                                Days infection
                                                     (c)                                                                                 (d)
                                                           12                                                                            IFN-ð?›¾
                          1000                                                                              2500
                                                                                      #                                                             #
                                                                                      âˆ—                                                             âˆ—
                                                                         #                                  2000
                                                                         âˆ—
                               750
        12 (pg/mL)




                                                                                          IFN- ð?›¾ (pg/mL)




                                                                                                            1500
                                                                     âˆ—                                                            #                          âˆ—
                               500                         #                                                                      âˆ—
                                                           âˆ—                      âˆ—                                                         âˆ—
                                                                                                            1000
                                              #
                               250            âˆ—      âˆ—                                                                    âˆ—                                      #
                                                                                                             500                                                 âˆ—        âˆ—
                                                                                                                                                                              #
                                                                                                                                                                              âˆ—
                                 0                                                                                0
                                      5            12              19           26                                        5             12             19             26
                                                  Days infection                                                                 Days infection

                                     WT                            WT infected                                        WT                                WT infected
                                     5-LOâˆ’/âˆ’                       5-LOâˆ’/âˆ’ infected                                   5-LOâˆ’/âˆ’                           5-LOâˆ’/âˆ’ infected

                                                    (e)                                                                                     (f)

Figure 3: Cytokine production spleen cells T. cruzi-infected mice. Spleen cells control, infected WT infected 5-LOâˆ’/âˆ’
mice (ð?‘› = 10/group) cultured medium  Data independent experiments. Kruskal-Wallis test (âˆ— ð?‘ƒ < 0.01 versus
uninfected group; # ð?‘ƒ < 0.05 versus infected WT mice).
8                                                                                                                                                                                                                                    Mediators Inflammation


                                                                                        Gr-1+                                                                                                                        Gr-1+ CD11c+
                                                           160                      #                                                                                                        50
                                                                                                                                                                                                                            #




                                                                                                                                                               Number spleen cells Ã—105
                             Number spleen cells Ã—105

                                                                                                                                                                                             40
                                                           120

                                                                                                                                                                                             30
                                                            80
                                                                                                        #                                                                                    20          #
                                                                                                                   #
                                                            40
                                                                                                                                                                                             10                                                         #

                                                             0                                                                                                                               0
                                                                      5          12             19                 26                                                                                    5              12                 19           26
                                                                           Days infection                                                                                                                     Days infection
                                                                                                                                                                                                                    (b)
                                                                                           +
                                                           300                    CD11b                                                                                                 400                                 F4/80+         #
                           Number spleen cells Ã—10 5




                                                                                                                                                       Number spleen cells Ã—10 5
                                                                                                                                                                                        300                                 #
                                                           200

                                                                                                                                                                                        200
                                                                                                                   #
                                                                                                        #
                                                           100
                                                                                    #
                                                                     #                                                                                                                  100
                                                                                                                                                                                                          #

                                                            0                                                                                                                                 0
                                                                     5           12             19                 26                                                                                     5              12             19              26
                                                                           Days infection                                                                                                                    Days infection
                                                                 WT                             WT infected                                                                                           WT                             WT infected
                                                                 5-LOâˆ’/âˆ’                        5-LOâˆ’/âˆ’ infected                                                                                      5-LOâˆ’/âˆ’                        5-LOâˆ’/âˆ’ infected
                                                                              (c)                                                                                                                                     (d)
                                                                                                                       Number parasites recovered Mð?œ™
        Number parasites associated Mð?œ™




                                                 16                                                 #                                                                   200000


                                                 12                                                                                                                     150000


                                                     8                                                                                                                  100000


                                                     4                                                                                                                           50000

                                                                                                                                                                                                                                                #
                                                     0                                                                                                                                            0
                                                                     WT                           5-LOâˆ’/âˆ’                                                                                                     WT                           5-LOâˆ’/âˆ’
                                                                            (e)                                                                                                                                       (f)

Figure 4: Quantitative functional leukocyte responses T. cruzi infection.   Gr1+ cell (neutrophils); (b) Gr1+ CD11c+ cell (pDC cells);
(c) CD11b+ cell (myeloid lineage cell marker, Mac-1); (d) F4/80+ cell (macrophages) numbers spleen.

 stimulated anti-CD3ð?œ€ presented partially restored                                                                                                          measured (Figure 3), 2. Spleen cells
proliferative capacity.                                                                                                                                               collected infected WT mice day 12 stimulated
    Spleen cells collected infected mice days                                                                                                            anti-CD3ð?œ€ produced significant amounts type 1
12 26 inoculation, stimulated                                                                                                         cytokine (Th1) IFN-ð?›¾, type 2 cytokine (Th2) 10, anti-CD3ð?œ€. supernatants tested pres-                                                                                                            low levels 2 (Figure 7(b)). contrast, anti-
ence IFN-ð?›¾ 10, abundant cytokines                                                                                                           CD3ð?œ€-stimulated spleen cells collected infected 5-LOâˆ’/âˆ’
secreted spontaneously spleen cells infected mice                                                                                                             mice day 12 presented bias produce predominantly,
Mediators Inflammation                                                                                                                                                                    9

                                                                                                                                                      Anti-T. cruzi
                                                           +                                                             2800
                                                   CD19 B-cells
                                  250                                                                                    2400




                                                                                          Reciprocal serum dilution
                                                                                     #
                                                                                                                         2000
    Number spleen cells Ã—105




                                  200
                                                                         #                                                                                              #
                                                                                                                         1600
                                  150
                                                                                                                         1200                                                            #
                                            #
                                  100                                                                                     800
                                                      #                                                                                           #
                                                                                                                          400
                                  50
                                                                                                                            0




                                                                                                                                IgG


                                                                                                                                       IgG1


                                                                                                                                              IgG2a




                                                                                                                                                                      IgG


                                                                                                                                                                              IgG1


                                                                                                                                                                                     IgG2a
                                    0
                                            5           12               19          26
                                                  Days infection                                                               Day 19                                 Day 26
                                        WT                        WT infected                                                    WT
                                        5-LOâˆ’/âˆ’                   5-LOâˆ’/âˆ’ infected                                               5-LOâˆ’/âˆ’
                                                                                                                                                    (b)

Figure 5:   Splenic CD19+ B-cell counts control, infected WT infected 5-LOâˆ’/âˆ’ mice (ð?‘› = 10/group). Data independent experiments. Studentâ€™s ð?‘¡-test (# ð?‘ƒ < 0.01 versus infected WT mice). (b) T. cruzi-specific serum antibody titers infected WT 5-LOâˆ’/âˆ’ mice (ð?‘› = 10/group). Data independent experiments. # ð?‘ƒ < 0.001 versus infected WT mice.



 greater quantities, Th1 cytokines, producing lower                                                   infected 5-LOâˆ’/âˆ’ mice infected WT mice. 
quantities Th2 cytokines greater quantities 2.                                                 differences infected 5-LOâˆ’/âˆ’ mice
     day 26 inoculation, infected WT mouse spleen                                                  infected WT mice terms numbers CD8+
cells stimulated anti-CD3ð?œ€ exhibited bias pro-                                                    effector/memory T cells.
duce Th1 cytokine IFN-ð?›¾ quite high amounts                                                          questioned kinetic differences (Figure 7(b)).  infected 5-LOâˆ’/âˆ’ mouse spleen cells                                                 infected 5-LOâˆ’/âˆ’ mice infected WT mice terms receiving treatment presented alterations                                                increase CD4+ CD25+ T cell numbers (Figure 6(e))
cytokine production profile, sustained capacity produce                                                related involvement regulatory T cells detectable levels 2, high  predominant) levels                                                model. Figure 7(f) shows T. cruzi-infected mice exhib- Th1 cytokines, low levels Th2 cytokines, day                                            ited increased numbers CD4+ CD25+ GITR+ regulatory T
12.                                                                                                         cells. infected WT mice 5-LOâˆ’/âˆ’ mice exhibited
     anti-CD3ð?œ€ promotes polyclonal T-cell stimula-                                                  similar numbers splenic CD4+ CD25+ GITR+ regulatory T
tion, investigated IFN-ð?›¾ 10 pro-                                                     cells. Unexpectedly, numbers CD4+ CD25+ GITR+ duced primed T. cruzi-specific cells. tested recall                                               spleen lower uninfected 5-LOâˆ’/âˆ’ mice responses spleen cells collected day 12 inoculation                                             uninfected WT mice. cultured soluble T. cruzi antigens. T. cruzi-specific
cells infected WT mice cultured nominal antigens                                                  3.10. Levels LTC4 , Serum Nitrite Levels, Protein
produced IFN-ð?›¾ 10, T. cruzi-specific cells                                                   Extravasation Peritoneal Cavity Acute infected 5-LOâˆ’/âˆ’ mice produced recall response,                                                      Phase T. cruzi Infection. cys-LTs mediate detrimental
characterized high levels IFN-ð?›¾ lower levels                                                vascular effects systemic infections sepsis [23].
10, culture.                                                                                    Vasoactive mediators produced involved
     results regarding recall response suggested                                              mortality animals acute phase T.
presence functional parasite-specific effector/memory                                                    cruzi infection [35].  examined levels T cells.  sought study populations                                                   vasoactive mediators metabolites, LTC4 ,
effector/memory T cells. shown Figure 7, infected mice                                                measured protein leak  marker vascular
exhibited increased numbers splenic effector/memory T                                                    permeability) time point infected WT mice cells CD4+ CD8+ subsets, including CD4+ CD45RBlow ,                                                  high mortality infected 5-LOâˆ’/âˆ’ mice  CD4+ CD44high CD62Llow , CD8+ CD45RBlow , CD8+ CD                                                       illustrated Figure 8, capacity produce LTC4 44high CD62Llow , day 26 inoculation. Inter-                                                       markedly upregulated peritoneal cells infected WT
estingly, numbers effector/memory T cells                                                            mice day 22 inoculation,  expected, CD4+ CD45RBlow CD4+ CD44high CD62Llow higher                                                       infected 5-LOâˆ’/âˆ’ mice produced detectable levels 10                                                                                                                                                                                                               Mediators Inflammation


                                                                CD4+ CD69+                                                                                                                             CD8+ CD69+
                                             30                                                                                                                        12
               Number spleen cells Ã—105




                                                                                                                                        Number spleen cells Ã—105
                                             20                                                                                                                        8

                                                                                                                                                                                                                                #

                                             10                                                                               #                                        4
                                                                                                                                                                                                                    #
                                                                                                                                                                                                         #


                                             0                                                                                                                         0
                                                  5       12                                             19                   26                                                        5             12             19        26
                                                          Days infection                                                                                                                  Days infection
                                                                                                                                                                                                     (b)
                                                                      +
                                                               CD4 CD44                              +                                                                                              CD8+ CD44+
                                      300                                                                                                                              125




                                                                                                                                         Number spleen cells Ã—105
        Number spleen cells Ã—105




                                                                                                                                                                       100
                                      200
                                                                                                                                                                        75                                                      #
                                                                                                                              #                                                                                         #
                                                                                                              #                                                         50
                                      100                         #                                                                                                                                          #
                                                      #                                                                                                                 25

                                              0                                                                                                                             0
                                                      5         12             19                                             26                                                            5          12             19        26
                                                          Days infection                                                                                                                   Days infection
                                                                (c)                                                                                                                                    (d)
                                                                                                                                                   +                            +
                                                                                                                                  CD4 CD25
                                                                                                    30
                                                                      Number spleen cells Ã—105




                                                                                                    20
                                                                                                                                                                                                   #


                                                                                                    10                              #                                               #
                                                                                                                  #



                                                                                                    0
                                                                                                                  5               12             19                                               26
                                                                                                                            Days infection

                                                                                                              WT                                                       5-LOâˆ’/âˆ’
                                                                                                              WT infected                                              5-LOâˆ’/âˆ’ infected
                                                                                                                                  (e)

Figure 6: Splenic T-cell subpopulations control, infected WT infected 5-LOâˆ’/âˆ’ mice (ð?‘› = 8/group). Data independent experiments. Studentâ€™s ð?‘¡-test (# ð?‘ƒ < 0.01 versus infected WT mice).



LTC4 . time point, infected 5-LOâˆ’/âˆ’ mice presented                                                                                          degree protein leakage similar groups
significantly lower serum nitrite levels did infected WT                                                                                       infected animals. 5-LOâˆ’/âˆ’ mice presented
mice. addition, peritoneal cavity protein extravasation                                                                                      tendency greater protein leakage did WT
assays (Figure 8(c)) indicated days 14 19,                                                                                          mice, difference significant.  day
Mediators Inflammation                                                                                                                                                                                                                                                                                        11


                                                                                                                                                                                                                               9000                              T cells cytokine profile
                                                                                                                                                                                                                                                                  #




                                                                                                                                                                                                     Cytokines (pg/mL)
                                                                                       T cell proliferation                                                                                                                                                                                              #
                              1.0                                                                                                                    5                                                                         6000




                                                                                                                                                          Stimulation index (SI)
                              0.8                                                                                                                    4
          MTT (570 nm)




                              0.6                                                                                                                    3                                                                         3000
                                                                                                                                                                                                                                                                                                             #
                                                                                                                                     âˆ—#
                                                                                                                                                                                                                                                                       #                             #
                              0.4                                                                                                                    2                                                                                                       #
                                                                                                                                                                                                                                              0
                                                                                         âˆ—
                              0.2                                                                                                                    1
                                                                                                                                                                                                                                                  WTi +          5-LOâˆ’/âˆ’            WTi +          5-LOâˆ’/âˆ’ +
                                                                                                                                                                                                                                                  ð?›¼CD3                              ð?›¼CD3             ð?›¼CD3
                                                                                                                                                                                                                                                                 + ð?›¼CD3
                              0.0                                                                                                                                                                                                                    Day 12                                      Day 26
                                                                                                                                                     0
                                                                 WT + ð?›¼CD3 WT inf. +                   5-LO    âˆ’/âˆ’
                                                                                                             + 5-LO   inf. +         âˆ’/âˆ’                                                                                                            2                                    10
                                                                            ð?›¼CD3                        ð?›¼CD3       ð?›¼CD3                                                                                                                             IFN-ð?›¾
                                                                                                                                                                                                                                                                          (b)

                                                                 3000                  T. cruzi Ag-induced cytokines
                                                                                                                                                     âˆ—#
                                                                                                                                                                                                                                                                       CD45RBlow
                                                                 2500
                                                                                                                                     âˆ—#                                                                                                      12                        âˆ—#

                                                                                                                                                                                                             Number T cells spleen Ã—106
                                                                 2000
                     Cytokines (pg/mL)




                                                                                                       âˆ—
                                                                 1500                                                #                                                                                                                        8               âˆ—

                                                                 1000                   âˆ—                  âˆ—

                                                                                                                                                                                                                                                                                                 âˆ—       âˆ—
                                                                  500                                                                                        âˆ—#                                                                               4
                                                                                                                         #
                                                                      0
                                                                                   (10 ð?œ‡g)
                                                                           WTi +
                                                                          medium




                                                                                                   (50 ð?œ‡g)

                                                                                                                 5-LOâˆ’/âˆ’ +
                                                                                   WTi +




                                                                                                                                                 5-LOâˆ’/âˆ’ +
                                                                                                   WTi +




                                                                                                                                   5-LOâˆ’/âˆ’ +
                                                                                   Tc Ag


                                                                                                   Tc Ag




                                                                                                                                     (10 ð?œ‡g)


                                                                                                                                                   (50 ð?œ‡g)
                                                                                                                 medium




                                                                                                                                                    Tc Ag
                                                                                                                                      Tc Ag




                                                                                                                                                                                                                                              0
                                                                                                                                                                                                                                                          CD4+                         CD8+

                                                                              IFN-ð?›¾                                                                                                                                                                 WT                               WT infected
                                                                              10                                                                                                                                                                 5-LOâˆ’/âˆ’                          5-LOâˆ’/âˆ’ infected

                                                                                                   (c)                                                                                                                                                                     (d)
                                                                                                           low
                                                                 35                              CD62L
                                                                                                 âˆ—#                                                                                                                      4.5                              CD4+ CD25+ GITR+
                              6




                                                                                                                                        âˆ—
                                  Number T cells spleen Ã—10




                                                                 30
                                                                                                                                                                                                                                                                        âˆ—
                                                                                                                                                                                   Number T cells spleen Ã—106




                                                                 25                         âˆ—                                                                                                                            3.6                                                                 âˆ—
                                                                                                                                                 âˆ—
                                                                 20
                                                                                                                                                                                                                         2.7
                                                                 15
                                                                 10                                                                                                                                                      1.8

                                                                  5                                                                                                                                                      0.9
                                                                                                                                                                                                                                                                      âˆ™
                                                                  0
                                                                                   +            high                           +            high
                                                                            CD4 CD44                                 CD8 CD44                                                                                            0.0

                                                                           WT                                            WT infected                                                                                                               WT                              WT infected
                                                                           5-LOâˆ’/âˆ’                                       5-LOâˆ’/âˆ’ infected                                                                                                          5-LOâˆ’/âˆ’                         5-LOâˆ’/âˆ’ infected

                                                                                                  (e)                                                                                                                                                                 (f)

Figure 7: Splenic T-cell properties, effector/memory T cells, regulatory T cells control, infected WT infected 5-LOâˆ’/âˆ’ mice (ð?‘› =
8/group):   proliferation; (b) cytokine production profile anti-CD3 stimulation; (c) Th1/Th2 cytokine recall response soluble
T. cruzi antigen. âˆ— ð?‘ƒ < 0.001 versus uninfected group; # ð?‘ƒ < 0.001 versus infected WT mice. (d) CD4+ CD45RBlow CD8+ CD45RBlow ; (e)
CD4+ CD44high CD62Llow CD8+ CD44high CD62Llow ; (f) CD4+ CD25+ GITR+ . Stimulation index (SI) generated ratio OD (570 nm) obtained noninfected/infected cells. Data independent experiments. Studentâ€™s ð?‘¡-test (# ð?‘ƒ < 0.01 versus
infected WT mice).
12                                                                                                                                                          Mediators Inflammation


                                      120                                                                        900                                            âˆ—
                                                                            âˆ—
                 Serum nitrite (ð?œ‡M)




                                                                                                 LTC 4 (pg/mL)
                                          80                                                                     600

                                                                                           âˆ—#


                                          40                                                                     300



                                                                                                                                                                      #        #
                                           0                                                                           0

                                                 WT                     WT infected                                              WT                         WT infected
                                                 5-LOâˆ’/âˆ’                5-LOâˆ’/âˆ’ infected                                         5-LOâˆ’/âˆ’                    5-LOâˆ’/âˆ’ infected

                                                                                                                                                (b)
                                      6
                                                                                    âˆ—                                  100

                                      5                                                                                90
                                                                                                                       80
                                      4                                âˆ—                                               70
                                                                                                        Survival ( )
     Evans blue (mg/mL)




                                                                                                                       60                                                      P < 0.005
                                      3               âˆ—
                                                               âˆ—                                                       50
                                                                                                                       40
                                      2                                                      #
                                                                                                                       30
                                                                                                                       20
                                      1
                                                                                                                       10
                                      0                                                                                    0
                                                 14               19                    22                                   0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40
                                                           Days infection                                            Vehicle montelukast + + + + + + + + + + +
                                                                                                                                               Days infection
                                               WT                                                                                 Vehicle
                                               5-LOâˆ’/âˆ’                                                                            Montelukast (10 mg/kg)
                                                              (c)                                                                                   (d)

Figure 8: Levels vasoactive/vasomotor mediators relevance cys-LTs mice acutely infected T. cruzi (ð?‘› = 10/group):   total
serum nitrite (nitrite/nitrate) levels (b) LTC4 production peritoneal cells stimulation calcium ionophore. Data independent experiments. # ð?‘ƒ < 0.001 versus infected WT mice. (c) Protein extravasation peritoneal cavity (colorimetric
assay extravascular dye leakage). Dotted line indicates mean Evans blue D.O. control mice. Data experiment
representative separate experiments. # ð?‘ƒ < 0.05 versus infected WT mice. (d) Effect cys-LT receptor antagonist survival T. cruzi-infected mice: (black squares) vehicle-treated infected WT mice (gray squares) infected WT mice treated montelukast
(10 mg/kg) postinoculation day 14 postinoculation day 34 monitored 26 days. Data experiment representative separate experiments. Wilcoxon signed-rank test # ð?‘ƒ < 0.005 versus vehicle-treated infected WT mice.



22, protein leakage peritoneal cavity considerably                                            mortality) achieved treatment montelukast
greater infected WT mice infected 5-LOâˆ’/âˆ’                                             (Figure 8(d)).
mice.

3.11. Treatment Infected Mice cys-LTs Receptor Antago-                                           4. Discussion
nist Mortality. determine cysLTs involved mortality T. cruzi-infected mice, WT mice                                                 Leukotrienes, products 5-LO pathway arachidonic
subjected infection T. cruzi treated cysLT                                          acid metabolism, potent immunomodulatory lipids receptor antagonist montelukast day 14 day 34                                              increasingly recognized regulate innate adaptive
inoculation. day 40 inoculation, mortality                                                 immune responses parasitic infections [36]. Despite vehicle-treated control WT mice 82 ,                                                     relevance LTs T. cruzi killing macrophages vitro
moderately significant degree protection (reduction 48                                             controlling blood parasite numbers vivo
Mediators Inflammation                                                                                                        13

[26, 37, 38], oxidative balance 5-LOâˆ’/âˆ’ T. cruzi infected   induce 1ð?›½ production [45]; seen mice related 5-LO-pathway independent [39].         unique inducer, presume  5-LOâˆ’/âˆ’ mice, 
Different results cytokines productions            1ð?›½ 6 induced T. cruzi PAMPs (Pathogen
observed acute phase T. cruzi Y strain infection     Associated Molecular Patterns), previously described [46]. 5-LOâˆ’/âˆ’ mice related resistance [40]              murine models fungal bacterial infection, susceptibility [41]. localized presence TCD8+         suggested pharmacological impairment LT
TCD4+ heart demonstrated T. cruzi 5-LOâˆ’/âˆ’            biosynthesis hindered production Th1 cytokines
infected mice [40], cell types eicosanoid         12 IFN-ð?›¾ [20, 21].  model, 5-LOâˆ’/âˆ’
mediators investigated complete immune         T. cruzi infected mice exhibited increased capacity response analysis. novel finds study focus          produce 12 IFN-ð?›¾. similar result obtained vivo role 5-LO metabolites cells related           infection models using 5-LOâˆ’/âˆ’ mice [22, 29, 30], innate/adaptive immune responses, resistance, mortality        capacity essential achieving protective acute phase T. cruzi murine infection.         immunity pathogens mice [22, 47]. Previous
important note analysis performed day sixteen        studies demonstrated quality quantity infection using infected mice survived     inflammatory mediators 12, IFN-ð?›¾, 10 time point. Furthermore, results     released weeks infection critical 5-LOâˆ’/âˆ’ mice infection, using T. cruzi Colombian strain,       driving generation parasite-specific effector T cells [48]
tributing better understanding immune response         suggest early 12 IFN-ð?›¾ production pathology Chagasâ€™ disease.                              infection regulated LTs. probable splenic
    data peritoneal cells infected WT           Gr-1+ CD11c+ plasmacytoid dendritic cells, Gr-1+ neutrophils,
mice develop enhanced capacity produce LTB4 , LTC4 ,         F4/80+ macrophages sources 12 IFN-ð?›¾, PGE2 compared cells obtained uninfected              numbers cells significantly
mice, implicating LTs PGs host response T.           higher 5-LOâˆ’/âˆ’ infected mice WT infected mice.
cruzi parasitic infection. Compared WT, 5-LOâˆ’/âˆ’ mice          cell types increased T.
developed significantly reduced parasitemia, lower tissue          cruzi infection models [10, 49], relevant
parasitism, inflammatory cell infiltrates,        source 12 IFN-ð?›¾ setting protozoal infection significant improvement survival. curve             [50, 51]. Furthermore, 12-producing CD11c+ cells parasitemia showed different profile compared           elevated 5-LOâˆ’/âˆ’ model M. tuberculosis
previous publications [40, 41].  publications        infection [22]. different                                                                          evidence LTs contribute process different trypomastigotes used infect exper-
                                                                   T-cell activation/migration different models [52, 53]. imental groups mice, work used cell culture-
                                                                   results demonstrated importance 5-LO products T-
derived trypomastigotes [40] used mice-derived
                                                                   cell activation T. cruzi infection. reduction
trypomastigotes [41].  works used Y strain
                                                                   numbers activated splenic T cells achieved T. cruzi, used Colombian strain.
    scenarios suggest LTs deficiency renders mice       infected 5-LOâˆ’/âˆ’ mice, T cells animals, resistant T. cruzi infection conversely 5-        opposed WT mice, presented partially
LO products confer susceptibility T. cruzi virulence.       recovered capacity proliferate anti-CD3ð?œ€ stimulation
production proinflammatory cytokines 1ð?›½, 6,            produce 2 anti-CD3ð?œ€ stimulation 12, TNF-ð?›¼, IFN-ð?›¾ presence parasite-specific         presence T. cruzi soluble antigens. accordance
T cells generating predominantly IFN-ð?›¾ low levels           previous studies showing LTs inhibit T cell 10 associated increased efficiency 5-           proliferation 2 production [54] susceptibility
                                                                   T. cruzi infection associated elevated numbers
LOâˆ’/âˆ’ mice control infection blood                                                                    polyclonal activated T cells spleen [55] tissue compartments. fact, later phases infection,
                                                                   splenic T cell unresponsiveness mitogens inability
parasitemia tissue parasitism significantly reduced
                                                                   secrete 2 [56]. Furthermore, resistance T. cruzi 5-LOâˆ’/âˆ’ mice accordance previous studies      infection 5-LOâˆ’/âˆ’ mice, contrast susceptibility
showing cytokines 1ð?›½, 6, 12, TNF-ð?›¼,      WT mice, correlated elevated numbers splenic
IFN-ð?›¾ play relevant role host killing mechanisms                                                                    effector/memory T cells, including CD4+ CD45RBlow T. cruzi [8].
    Consistent data, evidence LTs induce    CD4+ CD44high CD62Llow , end acute phase
TNF-ð?›¼ [38] PGE2 [42] release. models,           infection. Elevated numbers T cells expressing observed drug-induced genetic LTs deficiency          phenotypes associated IFN-ð?›¾ production increased PGE2 levels [43]. observed 5-LOâˆ’/âˆ’ mice          resistance T. cruzi infection [11].
presented sustained potential produce PGE2 late             correlation resistance infection phase infection. support findings LTB4           Th1 bias CD4+ T cells identified 5-
induced 6, healthy patients subjected inhalation          LOâˆ’/âˆ’ mice infected pathogens, including M.
swine house dust treated 5-LO inhibitor showed            tuberculosis [22] T. gondii [57]. bias IFN-ð?›¾
elevated 6 serum levels [44]. addition, LTB4           production T cells 5-LOâˆ’/âˆ’ mice observed
14                                                                                                     Mediators Inflammation

following infections typical Th2-inducing pathogens            mouse models [65, 66] suggest S. mansoni [29] S. venezuelensis [30] leading           relevant vivo. alteration B cell activation observed animals resistant susceptible              T. cruzi 5-LOâˆ’/âˆ’ infected mice explain lower serum infection, respectively. CD4+ CD25+ T cells number           levels parasite-specific IgG IgG2a end abnormality T. cruzi 5-LOâˆ’/âˆ’ infected mice led          acute phase infection. previously described LT investigate CD4+ CD25+ regulatory T cells.         deficiency altered specific-immunoglobulin class switching WT 5-LOâˆ’/âˆ’ infected mice presented                specific pathogens vivo [29, 30].  LTs similar numbers splenic CD4+ CD25+ GITR+ regulatory T            affect parasite-specific antibody levels infection cells. does completely rule involvement         parasite-specific IgG IgG2a involved 5-
CD4+ CD25+ regulatory T cells present model. fact,        LOâˆ’/âˆ’ mouse resistance T. cruzi infection. reinforces recently demonstrated CD4+ CD25+ regulatory T           previous observation host resistance acute
cells play limited role acute chronic phases       phase T. cruzi infection achieved absence of T. cruzi infection [58].                                         B cells [67].
     Phagocytes long known play important                Animal mortality acute phase T. cruzi
role T. cruzi killing process [59]. known    infection associated multiple factors, including
IFN-ð?›¾ major mediators conferring resistance           parasite strain virulence [68], anemia [69], increased levels T. cruzi [60]. Macrophage (F4/80+ ) numbers IFN-ð?›¾            TNF-ð?›¼, T-cell hyperactivity [70]. fact, T. cruzi-infected increased T. cruzi 5-LOâˆ’/âˆ’ infected mice.       mice shown extremely sensitive sepsis-like vitro infection assays revealed activated PMs 5-       inducers die evidence shock syndrome [69].
LOâˆ’/âˆ’ mice strongly associated efficient para-       demonstrated T. cruzi-infected WT mice presented,
site killing WT macrophages. results corroborate         acute phase, upregulated production LTB4 vivo findings 5-LOâˆ’/âˆ’ mice efficient        LTC4 , high serum nitrite levels. addition, controlling parasitemia, contrasts previous vitro       analysis protein extravasation peritoneal cavity
findings showing LTs foster intracellular parasite killing [26,     revealed infected WT mice exhibited stronger protein
38].  suggested 5-LOâˆ’/âˆ’ mice oxidative     leakage compared 5-LOâˆ’/âˆ’ mice. Previous studies
stress occurs leukotriene-independent pathway,        showed LTs induce production macrophages increase erythrocyte oxidative stress observed      endothelial cells [38], high levels production animals [39]. Differences experimental design            associated increased mortality T. cruzi-infected study previously published investigations warrant           mice [71]. LTs play critical role vascular events discussion. differences results explained         mortality mice subjected cecal ligation puncture macrophage activation responsiveness          model sepsis [23]. observed T. cruzi-infected
LTs. used classic activated macrophages (M1) vitro            WT mice treated montelukast presented significant
[61], previous studies showing enhanced pathogen-           reduction mortality, providing evidence cys-LTs killing properties LT-stimulated macrophages employed            involved vascular events associated mortality ani-
resident peritoneal macrophages [26, 37], thioglycollate-           mals acute phase T. cruzi infection. notable
elicited macrophages [28, 38], alveolar macrophages [18].        montelukast treatment effective increasing functional differences different types           survival contrast observed T. cruzi-infected 5-
macrophages remarkable consistently               LOâˆ’/âˆ’ mice. deaths montelukast-treated animals
described [62, 63]. increased capacity macrophages           attributable presence 5-LO products,
                                                                    LTB4 , indirect effect inducing vasoactive 5-LOâˆ’/âˆ’ mice kill intracellular pathogens pre-
                                                                    mediators [72] thromboxane [73]. 
viously described M. tuberculosis [22]. findings
                                                                    unlike WT, 5-LOâˆ’/âˆ’ infected mice sustain production underscore relevance IFN-ð?›¾ killing activity                                                                     TNF-ð?›¼ 6. finding surprising, macrophages 5-LOâˆ’/âˆ’ mice resistance T. cruzi infection,       cytokines shown vasoactive properties [35]. data shed light LXA4 involved
                                                                         reasonable mechanism explain WT mice mor- parasite resistance mice, described M. tuberculosis infection [22].                                     tality acute phase T. cruzi infection involves
     Analysis B cells indicated T. cruzi 5-LOâˆ’/âˆ’ infected   capacity produce LTs, lead extreme
mice developed smaller increases numbers splenic          bias spleen cells T-cells secrete high levels CD19+ B cells weeks did WT mice,          Th1 cytokines, IFN-ð?›¾, low levels  followed increased numbers splenic CD19+         10. addition, downregulated production PGE2 B cells following weeks. elevated numbers CD19+       relevant, PGE2 shown induce 10
B cells 5-LOâˆ’/âˆ’ mice later phase infection       production [74], inhibit production IFN-ð?›¾ T. indicate accumulation undifferentiated B cells          cruzi infection, promote increased production splenic compartment. hypothesis supported         [75]. advantage survival T. cruzi-5-LOâˆ’/âˆ’ infected
previous studies showing antibody-secreting B cells lose       mice represents complex contribution various effects CD19 marker [64]. Previous vitro findings showed           host defense, including capacity efficiently control LTs important activating B cells human           parasites produce detectable levels 10, increase
Mediators Inflammation                                                                                                                         15
 production PGE2 , lesser amounts                     infection involves minimal modulation host cell transcrip- inability produce cys-LTs.                                             tion,â€? Journal Biological Chemistry, vol. 277,  1, pp. 639â€“
                                                                                644, 2002.

5. Conclusions                                                              [8] L. E. Fichera, M. C. Albareda, S.  Laucella, M. Postan,
                                                                                â€œIntracellular growth trypanosoma cruzi cardiac myocytes findings demonstrated 5-LO deficiency altered                          inhibited cytokine-induced nitric oxide release,â€? Infection
eicosanoids cytokines production T. cruzi infec-                     Immunity, vol. 72,  1, pp. 359â€“363, 2004.
tion favored generation/maintenance protective                   [9] F. S. Machado, G.  Martins, J. C. S. Aliberti, F. L.  C.
immune responses.  provided evidence 5-LO-                       Mestriner, F. Q. Cunha, J. S. Silva, â€œTrypanosoma cruzi-
derived lipid mediators negative effect host survival                 infected cardiomyocytes produce chemokines cytokines
                                                                                trigger potent nitric oxide-dependent trypanocidal activ- acute phase infection.
                                                                                ity,â€? Circulation, vol. 102,  24, pp. 3003â€“3008, 2000.
                                                                           [10]  C. Monteiro, V. Schmitz, E. Svensjo et al., â€œCooperative
Conflict Interests                                                           activation TLR2 bradykinin B2 receptor required                                                                                 induction type 1 immunity mouse model subcutaneous authors declare conflict interests                      infection Trypanosoma cruzi,â€? Journal Immunology,
regarding publication paper.                                        vol. 177,  9, pp. 6325â€“6335, 2006.
                                                                           [11]  Nomizo, F. Cardillo, E. PostÂ´ol, L. P. Carvalho, Authorsâ€™ Contribution                                                           J. Mengel, â€œVð?›¾1 ð?›¾ð?›¿ T cells regulate type-1/type-2 immune
                                                                                responses participate resistance infection Adriana M. C. Canavaci Carlos  Sorgi contributed                          development heart inflammation Trypanosoma cruzi-
equally work.                                                           infected BALB/c mice,â€? Microbes Infection, vol. 8,  3, pp.
                                                                                880â€“888, 2006.
                                                                           [12] R. L. Tarleton, B. H. Koller,  Latour, M. Postan, â€œSuscepti-
Acknowledgments                                                                 bility ð?›½2-microglobulin-deficient mice Trypanosoma cruzi work supported Fundac  o Amparo                          infection,â€? Nature, vol. 356,  6367, pp. 338â€“340, 1992.
Pesquisa Estado SËœao Paulo (FAPESP, Foundation                   [13] D. F. Hoft,  R. Schnapp, C. S. Eickhoff, S. T. Rood- Support Research State SËœao Paulo). Adriana                    man, â€œInvolvement CD4+ Th1 cells systemic immunity
M. C. Canavaci recipient fellowship                        protective primary secondary challenges Brazilian Conselho Nacional Desenvolvimento CientÂ´Ä±fico                      Trypanosoma cruzi,â€? Infection Immunity, vol. 68,  1, pp.
                                                                                197â€“204, 2000.
e TecnolÂ´ogico (CNPq, National Council Scientific Technological Development).                                                [14] M. Peters-Golden, C. Canetti, P. Mancuso, M. J. Coffey,
                                                                                â€œLeukotrienes: underappreciated mediators innate immune
                                                                                responses,â€? Journal Immunology, vol. 174,  2, pp. 589â€“
References                                                                      594, 2005.
[1] K. Senior, â€œChagas disease: moving global elimina-             [15] M. Peters-Golden T. G. Brock, â€œ5-Lipoxygenase FLAP,â€?
    tion.,â€? Lancet infectious diseases, vol. 7,  9, p. 572, 2007.        Prostaglandins Leukotrienes Essential Fatty Acids, vol. 69,
                                                                                 2-3, pp. 99â€“109, 2003.
[2] L. O. Andrade N. W. Andrews,  Trypanosoma
    cruzi-host-cell interplay: Location, invasion, retention,â€? Nature      [16] C. N. Serhan, M. Hamberg, B. Samuelsson, â€œLipoxins:
    Reviews Microbiology, vol. 3,  10, pp. 819â€“823, 2005.                    novel series biologically active compounds formed                                                                                 arachidonic acid human leukocytes,â€? Proceedings [3]  Brener R. T. Gazzinelli, â€œImmunological control                                                                                 National Academy Sciences United States America,
    Trypanosoma cruzi infection pathogenesis Chagasâ€™
                                                                                vol. 81,  17, pp. 5335â€“5339, 1984.
    disease,â€? International Archives Allergy Immunology, vol.
    114,  2, pp. 103â€“110, 1997.                                         [17] T. Demitsu, H. Katayama, T. Saito-Taki, H. Yaoita, M.
[4] R. T. Gazzinelli,  P. Oswald, S. Hieny, S. L. James,                  Nakano, â€œPhagocytosis bactericidal action mouse peri-
     Sher,  microbicidal activity interferon-ð?›¾-treated                 toneal macrophages treated leukotriene B4,â€? International
    macrophages Trypanosoma cruzi involves L-                        Journal Immunopharmacology, vol. 11,  7, pp. 801â€“808, 1989.
    arginine-dependent, nitrogen oxide-mediated mechanism                  [18] M. B. Bailie, T. J. Standiford, L. L. Laichalk, M. J. Coffey, R.
    inhibitable interleukin-10 transforming growth factor-               Strieter, M. Peters-Golden, â€œLeukotriene-deficient mice
    ð?›½,â€? European Journal Immunology, vol. 22,  10, pp.                    manifest enhanced lethality Klebsiella pneumonia     2501â€“2506, 1992.                                                            association decreased alveolar macrophage phagocytic [5] C.  Santos-Buch, â€œAmerican trypanosomiasis: chagasâ€™ dis-                  bactericidal activities,â€? Journal Immunology, vol. 157,  12,
    ease,â€? International Review Experimental Pathology, vol. 19,             pp. 5221â€“5224, 1996.
    pp. 63â€“100, 1979.                                                      [19] N. Chen,  Restivo, C. S. Reiss, â€œLeukotrienes play
[6] S. E. B. Graefe, T. Streichert, B. S. Budde et al., â€œGenes             protective roles early experimental VSV encephalitis,â€?
    Chagas susceptibility loci differentially expressed             Journal Neuroimmunology, vol. 120,  1-2, pp. 94â€“102, 2001.
    T. cruzi-resistant mice candidates accounting impaired         [20]   Medeiros,  S Nunes, E. G. Soares, C. M. Peres, C. L.
    immunity,â€? PLoS  vol. 1,  1, article e57, 2006.                      Silva, L. H. Faccioli, â€œBlockade endogenous leukotrienes
[7] S. V. Avalos,  J. Blader, M. Fisher, J. C. Boothroyd, B.           exacerbates pulmonary histoplasmosis,â€? Infection Immu-
     Burleigh, â€œImmediate/early response Trypanosoma cruzi                 nity, vol. 72,  3, pp. 1637â€“1644, 2004.
16                                                                                                                   Mediators Inflammation

[21] C. M. Peres, L. Paula,   Medeiros et al., â€œInhibition        [35] C. HÂ¨olscher, M. Mohrs, W. J. Dai et al., â€œTumor necrosis
      leukotriene biosynthesis abrogates host control Mycobac-             factor ð?›¼-mediated toxic shock Trypanosoma cruzi-infected
      terium tuberculosis,â€? Microbes Infection, vol. 9,  4, pp.            interleukin 10-deficient mice,â€? Infection Immunity, vol. 68,
      483â€“489, 2007.                                                               7, pp. 4075â€“4083, 2000.
[22]  Bafica, C.  Scanga, C. Serhan et al., â€œHost control            [36]  P. Rogerio F. F. Anibal, â€œRole leukotrienes       Mycobacterium tuberculosis regulated 5-lipoxygenase-                  protozoan helminth infections,â€? Mediators Inflammation,
      dependent lipoxin production,â€? Journal Clinical Investi-             vol. 2012, Article ID 595694, 13 pages, 2012.
      gation, vol. 115,  6, pp. 1601â€“1606, 2005.                         [37] J. J. Wirth F. Kierszenbaum, â€œEffects leukotriene C4
[23] C. F. Benjamin, C. Canetti, F. Q. Cunha, S. L. Kunkel,                       macrophage association intracellular fate Try-
      M. Peters-Golden, â€œOpposing hierarchical roles                   panosoma cruzi,â€? Molecular Biochemical Parasitology, vol.
      leukotrienes local innate immune versus vascular responses               15,  1, pp. 1â€“10, 1985.
      model sepsis,â€? Journal Immunology, vol. 174,  3, pp.    [38]  Talvani, F. S. Machado, G. C. Santana et al., â€œLeukotriene B4
      1616â€“1620, 2005.                                                            induces nitric oxide synthesis Trypanosoma cruzi-infected
[24] H. Dâ€™Avila, C. G. Freire Lima, N. R. Roque et al., â€œHost                  murine macrophages mediates resistance infection,â€?
      cell lipid bodies triggered Trypanosoma cruzi infection              Infection Immunity, vol. 70,  8, pp. 4247â€“4253, 2002.
      enhanced uptake apoptotic cells associated         [39] C. L. Borges, R. Cecchini, V. L. H. Tatakihara et al., â€œ5-
      prostaglandin E2 generation increased parasite growth,â€?                 Lipoxygenase plays role control parasite burden
      Journal Infectious Diseases, vol. 204,  6, pp. 951â€“961, 2011.         contributes oxidative damage erythrocytes murine
[25] L. Xiao, P. S. Patterson, C. Yang,   Lal, â€œRole                   Chagasâ€™ disease,â€? Immunology Letters, vol. 123,  1, pp. 38â€“45,
      eicosanoids pathogenesis murine cerebral malaria,â€?                2009.
      American Journal Tropical Medicine Hygiene, vol. 60,        [40] W. R. Pavanelli, F. R. S. Gutierrez, F. S. Mariano et al., â€œ5-
      4, pp. 668â€“673, 1999.                                                       Lipoxygenase key determinant acute myocardial inflam-
[26] J. J. Wirth F. Kierszenbaum, â€œStimulatory effects                     mation mortality Trypanosoma cruzi infection,â€?
      leukotriene B4 macrophage association intracellu-               Microbes Infection, vol. 12,  8-9, pp. 587â€“597, 2010.
      lar destruction Trypanosoma cruzi,â€? Journal Immunology,          [41] C. Panis, T. L. Mazzuco, C.  F. Costa et al., â€œTrypanosoma
      vol. 134,  3, pp. 1989â€“1993, 1985.                                       cruzi: effect absence 5-lipoxygenase (5-LO)-derived
[27] J. J. Wirth F. Kierszenbaum, â€œEffects leukotriene C4                  leukotrienes levels cytokines, nitric oxide iNOS
      macrophage association intracellular fate Try-               expression cardiac tissue acute phase infection       panosoma cruzi,â€? Molecular Biochemical Parasitology, vol.               mice,â€? Experimental Parasitology, vol. 127,  1, pp. 58â€“65, 2011.
      15,  1, pp. 1â€“10, 1985.                                            [42]  Rossi,  M. Acquaviva, F. Iuliano, R. di Paola, S. Cuzzocrea,
[28] C. H. Serezani, J. H. Perrela, M. Russo, M. Peters-Golden, S.            L. Sautebin,  regulation prostaglandin biosynthesis
      Jancar, â€œLeukotrienes essential control Leishmania           leukotriene C4 elicited mice peritoneal macrophages
      amazonensis infection contribute strain variation                 activated lipopolysaccharide/ interferon-ð?›¾,â€? Journal       susceptibility,â€? Journal Immunology, vol. 177,  5, pp. 3201â€“          Leukocyte Biology, vol. 78,  4, pp. 985â€“991, 2005.
      3208, 2006.                                                           [43] R. S. Byrum, J. L. Goulet, R. J. Griffiths, B. H. Koller, â€œRole [29] W. E. Secor, M. R. Powell, J. Morgan, T.  Wynn, C. D.                  5-lipoxygenase-activating protein (FLAP) murine acute
      Funk, â€œMice deficient 5-lipoxygenase, leukocyte-                inflammatory responses,â€? Journal Experimental Medicine, vol.
      type 12- lipoxygenase, display altered immune responses              185,  6, pp. 1065â€“1075, 1997.
      infection Schistosoma mansoni,â€? Prostaglandins         [44] B. M. Larsson, M. Kumlin, B. M. Sundblad, K. Larsson, S. E.
      Lipid Mediators, vol. 56,  5-6, pp. 291â€“304, 1998.                       Dahl  L. Palmberg, â€œEffects 5-lipoxygenase inhibitor
[30] E. R. Machado, M. T. Ueta, E. V. LourencÂ¸o et al., â€œLeukotrienes             zileuton airway responses inhaled swine house dust       play role control parasite burden murine strongy-            healthy subjects,â€? Respiratory Medicine, vol. 100,  2, pp. 226â€“
      loidiasis,â€? Journal Immunology, vol. 175,  6, pp. 3892â€“           237, 2006.
      3899, 2005.                                                           [45] Y. Kageyama, Y. Koide, S. Miyamoto, T. O. Yoshida, T.
 [31] L. Xiao, P. S. Patterson, C. Yang,   Lal, â€œRole                  Inoue, â€œLeukotrien B4-induced interleukin-1ð?›½ synovial cells
      eicosanoids pathogenesis murine cerebral malaria,â€?            patients rheumatoid arthritis,â€? Scandinavian Journal
      American Journal Tropical Medicine Hygiene, vol. 60,              Rheumatology, vol. 23,  3, pp. 148â€“150, 1994.
      4, pp. 668â€“673, 1999.                                                 [46]  Talvani, C. S. Ribeiro, J. C. S. Aliberti et al., â€œKinetics [32] F. Cardillo, F. Q. Cunha, W. M. S. C. Tamashiro, M. Russo,                   cytokine gene expression experimental chagasic cardiomy-
      S. B. Garcia, J. Mengel, â€œNK 1.1+ Cells T-cell acti-                opathy: tissue parasitism endogenous IFN-ð?›¾ important
      vation euthymic thymectomized C57B1/6 mice                    determinants chemokine mRNA expression infection
      acute Trypanosoma cruzi infection,â€? Scandinavian Journal                 Trypanosoma cruzi,â€? Microbes Infection, vol. 2,  8,
      Immunology, vol. 55,  1, pp. 96â€“104, 2002.                               pp. 851â€“866, 2000.
[33]   Abrahamsohn,  P. G. da Silva, R. L. Coffman, â€œEffects      [47] J. Aliberti, S. Hieny, C. Reis Sousa, C. N. Serhan, 
      interleukin-4 deprivation treatment resistance                 Sher, â€œLipoxin-mediated inhibition 12 production DCs:
      Trypanosoma cruzi,â€? Infection Immunity, vol. 68,  4, pp.             mechanism regulation microbial immunity,â€? Nature
      1975â€“1979, 2000.                                                            Immunology, vol. 3,  1, pp. 76â€“82, 2002.
[34] G. N. R. Vespa, F. Q. Cunha, J. S. Silva, â€œNitric oxide         [48]  P. G. da Silva  Almeida Abrahamsohn,
      involved control Trypanosoma cruzi-induced parasitemia                â€œInterleukin-12 stimulation lymphoproliferative responses
      directly kills parasite vitro,â€? Infection Immunity,          Trypanosoma cruzi infection,â€? Immunology, vol. 104,  3,
      vol. 62,  11, pp. 5177â€“5182, 1994.                                       pp. 349â€“354, 2001.
Mediators Inflammation                                                                                                                         17

[49] O.  P. Alcaide, M. Fresno, â€œImmunosuppression                [65] K.  Yamaoka, H. E. Claesson,  Rosen, â€œLeukotriene B4
      acute Trypanosoma cruzi infection: involvement Ly6G               enhances activation, proliferation, differentiation human
      (Gr1+ )CD11b+ immature myeloid suppressor cells,â€? Interna-                  B lymphocytes,â€? Journal Immunology, vol. 143,  6, pp. 1996â€“
      tional Immunology, vol. 14,  10, pp. 1125â€“1134, 2002.                    2000, 1989.
[50] C. H. Liu, Y. T. Fan,  Dias et al., â€œCutting edge: dendritic cells   [66] C. Phillips, â€œInduction leukotriene production antigen
      essential vivo 12 production development               challenge enhances antibody affinity genetically selected
      resistance Toxoplasma gondii infection mice,â€? Journal            mice,â€? Cellular Immunology, vol. 136,  1, pp. 173â€“184, 1991.
      Immunology, vol. 177,  1, pp. 31â€“35, 2006.                      [67] D. E. Burgess W. L. Hanson, â€œTrypanosoma cruzi: T-cell
 [51] D. G. Mordue L. D. Sibley,  novel population Gr-1+ -               dependence primary immune response effects
      activated macrophages induced acute toxoplasmosis,â€?                  depletion T cells Ig-bearing cells immunological
      Journal Leukocyte Biology, vol. 74,  6, pp. 1015â€“1025, 2003.          memory,â€? Cellular Immunology, vol. 52,  1, pp. 176â€“186, 1980.
[52]  Prinz, C. Gregoire, H. Mollenkopf et al.,  type 1 cysteinyl     [68] V. Andrade, M. Barral-Netto, S. G. Andrade, â€œPatterns       leukotriene receptor triggers calcium influx chemotaxis              resistance inbred mice Trypanosoma cruzi determined
      mouse ð?›¼ð?›½- ð?›¾ð?›¿ effector T cells,â€? Journal Immunology,              parasite strain,â€? Brazilian Journal Medical Biological
      vol. 175,  2, pp. 713â€“719, 2005.                                         Research, vol. 18,  4, pp. 499â€“506, 1985.
[53]  M. Tager, S. K. Bromley, B. D. Medoff et al., â€œLeukotriene B4       [69] M. C. G. Marcondes, P. Borelli, N. Yoshida, M. Russo,
      receptor BLT1 mediates early effector T cell recruitment,â€? Nature           â€œAcute Trypanosoma cruzi infection associated anemia,
      Immunology, vol. 4,  10, pp. 982â€“990, 2003.                              thrombocytopenia, leukopenia, bone marrow hypoplasia:
[54] J. S. Goodwin, â€œRegulation T cell activation leukotriene               reversal nifurtimox treatment,â€? Microbes Infection, vol.
      B4,â€? Immunologic Research, vol. 5,  3, pp. 233â€“248, 1986.                2,  4, pp. 347â€“352, 2000.
[55] N. Nogueira, J. Ellis, S. Chaplan,  Cohn, â€œTrypanosoma           [70] S. Hamano, K. Himeno, Y. Miyazaki et al., â€œWSX-1 required
      cruzi: vivo vitro correlation T-cell activation           resistance Trypanosoma cruzi infection regulation       susceptibility inbred strains mice,â€? Experimental                 proinflammatory cytokine production,â€? Immunity, vol. 19,  5,
      Parasitology, vol. 51,  3, pp. 325â€“334, 1981.                            pp. 657â€“667, 2003.
[56]  Harel-Bellan, M. Joskowicz, D. Fradelizi, H. Eisen,              [71] F. Cardillo,  Nomizo, E. PostÂ´ol, J. Mengel, â€œNK1.1 cells       â€œModification T-cell proliferation interleukin 2 produc-             required control T cell hyperactivity Trypanosoma
      tion mice infected Trypanosoma cruzi,â€? Proceedings               cruzi infection,â€? Medical Science Monitor, vol. 10,  8, pp.
      National Academy Sciences United States America,           BR259â€“BR267, 2004.
      vol. 80,  11, pp. 3466â€“3469, 1983.                                 [72] H. Arndt, J. B. Russell,  Kurose, P. Kubes, D. N. Granger,
[57] J. Aliberti, C. Serhan,  Sher, â€œParasite-induced lipoxin               â€œMediators leukocyte adhesion rat mesenteric venules
      A4 endogenous regulator 12 production                       elicited inhibition nitric oxide synthesis,â€? Gastroenterol-
      immunopathology Toxoplasma gondii infection,â€? Journal                 ogy, vol. 105,  3, pp. 675â€“680, 1993.
      Experimental Medicine, vol. 196,  9, pp. 1253â€“1262, 2002.          [73] K. Sakata, S.-E. Dahl  M. BÂ¨ack,  contractile action
[58] J. Kotner R. Tarleton, â€œEndogenous CD4+ CD25+ regula-                    leukotriene B4 guinea-pig lung involves vascular
      tory T cells limited role control Trypanosoma              component,â€? British Journal Pharmacology, vol. 141,  3, pp.
      cruzi infection mice,â€? Infection Immunity, vol. 75,  2,           449â€“456, 2004.
      pp. 861â€“869, 2007.                                                    [74] G. Strassmann, V. Patil-Koota, F. Finkelman, M. Fong, T.
[59] D. M. Williams, S. Sawyer, J. S. Remington, â€œRole                     Kambayashi, â€œEvidence involvement interleukin 10       activated macrophages resistance mice infection               differential deactivation murine peritoneal macrophages
      Trypanosoma cruzi,â€? Journal Infectious Diseases, vol. 134,            prostaglandin E2,â€? Journal Experimental Medicine, vol. 180,
      6, pp. 610â€“614, 1976.                                                        6, pp. 2365â€“2370, 1994.
[60] F. Torrico, H. Heremans, M. T. Rivera, E. Van Marck,  Billiau,       [75] M.  Michelin, J. S. Silva, F. Q. C. Cunha, â€œInducible
      Y. Carlier, â€œEndogenous IFN-ð?›¾ required resistance                cyclooxygenase released prostaglandin mediates immunosup-
      acute Trypanosoma cruzi infection mice,â€? Journal                   pression acute phase experimental Trypanosoma cruzi
      Immunology, vol. 146,  10, pp. 3626â€“3632, 1991.                          infection,â€? Experimental Parasitology, vol. 111,  2, pp. 71â€“79,
                                                                                  2005.
 [61] D. O. Adams T.  Hamilton, â€œMolecular transduc-
      tional mechanisms IFNð?›¾ signals regulate
      macrophage development,â€? Immunological Reviews, vol. 97, pp.
      5â€“27, 1987.
[62] Y. Kita, T. Takahashi, N. Uozumi, L. Nallan, M. H. Gelb,       T. Shimizu, â€œPathway-oriented profiling lipid mediators       macrophages,â€? Biochemical Biophysical Research Commu-
      nications, vol. 330,  3, pp. 898â€“906, 2005.
[63] Q. Wu, Y. Feng, Y. Yang et al., â€œKinetics phenotype